Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 192

1.

KAT6A Syndrome: genotype-phenotype correlation in 76 patients with pathogenic KAT6A variants.

Kennedy J, Goudie D, Blair E, Chandler K, Joss S, McKay V, Green A, Armstrong R, Lees M, Kamien B, Hopper B, Tan TY, Yap P, Stark Z, Okamoto N, Miyake N, Matsumoto N, Macnamara E, Murphy JL, McCormick E, Hakonarson H, Falk MJ, Li D, Blackburn P, Klee E, Babovic-Vuksanovic D, Schelley S, Hudgins L, Kant S, Isidor B, Cogne B, Bradbury K, Williams M, Patel C, Heussler H, Duff-Farrier C, Lakeman P, Scurr I, Kini U, Elting M, Reijnders M, Schuurs-Hoeijmakers J, Wafik M, Blomhoff A, Ruivenkamp CAL, Nibbeling E, Dingemans AJM, Douine ED, Nelson SF; DDD Study,, Arboleda VA, Newbury-Ecob R.

Genet Med. 2018 Sep 24. doi: 10.1038/s41436-018-0259-2. [Epub ahead of print]

PMID:
30245513
2.

Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer: The AvaALL Randomized Clinical Trial.

Gridelli C, de Castro Carpeno J, Dingemans AC, Griesinger F, Grossi F, Langer C, Ohe Y, Syrigos K, Thatcher N, Das-Gupta A, Truman M, Donica M, Smoljanovic V, Bennouna J.

JAMA Oncol. 2018 Aug 30:e183486. doi: 10.1001/jamaoncol.2018.3486. [Epub ahead of print]

PMID:
30177994
3.

Brain imaging in early stage non-small cell lung cancer: still a controversial topic?

Schoenmaekers JJAO, Dingemans AC, Hendriks LEL.

J Thorac Dis. 2018 Jul;10(Suppl 18):S2168-S2171. doi: 10.21037/jtd.2018.06.68. No abstract available.

4.

Study Protocol of the NVALT25-ELDAPT Trial: Selecting the Optimal Treatment for Older Patients With Stage III Non-small-cell Lung Cancer.

Driessen EJM, Janssen-Heijnen MLG, Maas HA, Dingemans AC, van Loon JGM.

Clin Lung Cancer. 2018 Jul 9. pii: S1525-7304(18)30170-0. doi: 10.1016/j.cllc.2018.07.003. [Epub ahead of print]

PMID:
30097357
5.

The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial Irradiation.

Witlox WJA, Ramaekers BLT, Zindler JD, Eekers DBP, van Loon JGM, Hendriks LEL, Dingemans AC, De Ruysscher DKM.

Front Oncol. 2018 Jul 26;8:241. doi: 10.3389/fonc.2018.00241. eCollection 2018. Review.

6.

What you see is (not) what you get: tools for a non-radiologist to evaluate image quality in lung cancer.

de Jong EEC, Hendriks LEL, van Elmpt W, Gietema HA, Hofman PAM, De Ruysscher DKM, Dingemans AC.

Lung Cancer. 2018 Sep;123:112-115. doi: 10.1016/j.lungcan.2018.07.014. Epub 2018 Jul 18.

PMID:
30089580
7.

Invasive Aspergillosis Mimicking Metastatic Lung Cancer.

Vanfleteren MJEGW, Dingemans AC, Surmont VF, Vermaelen KY, Postma AA, Oude Lashof AML, Pitz CCM, Hendriks LEL.

Front Oncol. 2018 Jun 5;8:188. doi: 10.3389/fonc.2018.00188. eCollection 2018.

8.

Urinary Outcomes in Patients with Down's Syndrome and Hirschsprung's Disease.

Dingemans AJM, Reck-Burneo CA, Fuchs M, Sanchez AV, Lane VA, Hoover E, Maloof T, Weaver L, Levitt MA, Wood RJ.

Eur J Pediatr Surg. 2018 Jun 17. doi: 10.1055/s-0038-1660509. [Epub ahead of print]

PMID:
29909603
9.

Feeling bad or feeling good, does emotion affect your consumption of food? A meta-analysis of the experimental evidence.

Evers C, Dingemans A, Junghans AF, Boevé A.

Neurosci Biobehav Rev. 2018 Sep;92:195-208. doi: 10.1016/j.neubiorev.2018.05.028. Epub 2018 May 31. Review.

PMID:
29860103
10.

Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer.

Kuijpers CCHJ, Hendriks LEL, Derks JL, Dingemans AC, van Lindert ASR, van den Heuvel MM, Damhuis RA, Willems SM.

Lung Cancer. 2018 Jul;121:76-81. doi: 10.1016/j.lungcan.2018.05.006. Epub 2018 May 15.

11.

Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study.

De Ruysscher D, Dingemans AC, Praag J, Belderbos J, Tissing-Tan C, Herder J, Haitjema T, Ubbels F, Lagerwaard F, El Sharouni SY, Stigt JA, Smit E, van Tinteren H, van der Noort V, Groen HJM.

J Clin Oncol. 2018 Aug 10;36(23):2366-2377. doi: 10.1200/JCO.2017.77.5817. Epub 2018 May 22.

PMID:
29787357
12.

A structured bowel management program for patients with severe functional constipation can help decrease emergency department visits, hospital admissions, and healthcare costs.

Reck-Burneo CA, Vilanova-Sanchez A, Gasior AC, Dingemans AJM, Lane VA, Dyckes R, Nash O, Weaver L, Maloof T, Wood RJ, Zobell S, Rollins MD, Levitt MA.

J Pediatr Surg. 2018 Sep;53(9):1737-1741. doi: 10.1016/j.jpedsurg.2018.03.020. Epub 2018 Mar 24.

PMID:
29773453
13.

A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3).

Forster M, Hackshaw A, De Pas T, Cobo M, Garrido P, Summers Y, Dingemans AC, Flynn M, Schnell D, von Wangenheim U, Loembé AB, Kaiser R, Lee SM.

Lung Cancer. 2018 Jun;120:27-33. doi: 10.1016/j.lungcan.2018.03.007. Epub 2018 Mar 9.

14.

Geriatric Assessment for Older Patients with Non-small Cell Lung Cancer: Daily Practice of Centers Participating in the NVALT25-ELDAPT Trial.

Driessen EJM, van Loon JGM, Maas HA, Dingemans AC, Janssen-Heijnen MLG.

Lung. 2018 Aug;196(4):463-468. doi: 10.1007/s00408-018-0116-8. Epub 2018 Apr 12.

PMID:
29651598
15.

PD-(L)1 Inhibition and Cardiac Damage: A Relevant Toxicity?

De Ruysscher D, Dingemans AM, Vooijs M, Heymans S.

J Thorac Oncol. 2018 Apr;13(4):478-479. doi: 10.1016/j.jtho.2018.02.008. No abstract available.

PMID:
29576288
16.

Health literacy and health-related quality of life in patients with anorectal malformations: A comparison between a charity hospital in Honduras and a tertiary care center in the United States.

Dingemans AJM, Krois W, Rios JC, Wood RJ, Levitt MA, Reck-Burneo CA.

J Pediatr Surg. 2018 Oct;53(10):1951-1954. doi: 10.1016/j.jpedsurg.2018.02.053. Epub 2018 Feb 23.

PMID:
29550037
17.

Screening for Binge Eating Disorder in people with obesity.

Wever MCM, Dingemans AE, Geerets T, Danner UN.

Obes Res Clin Pract. 2018 May - Jun;12(3):299-306. doi: 10.1016/j.orcp.2018.02.002. Epub 2018 Mar 9.

PMID:
29530586
18.

Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey.

Levy A, Faivre-Finn C, Hasan B, De Maio E, Berghoff AS, Girard N, Greillier L, Lantuéjoul S, O'Brien M, Reck M, Dingemans AC, Novello S, Berghmans T, Besse B, Hendriks L; Young Investigators EORTC Lung Cancer Group (YI EORTC LCG).

Eur J Cancer. 2018 Apr;93:37-46. doi: 10.1016/j.ejca.2018.01.067. Epub 2018 Feb 21.

PMID:
29477100
19.

New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management.

Derks JL, Leblay N, Lantuejoul S, Dingemans AC, Speel EM, Fernandez-Cuesta L.

J Thorac Oncol. 2018 Jun;13(6):752-766. doi: 10.1016/j.jtho.2018.02.002. Epub 2018 Feb 14. Review. Erratum in: J Thorac Oncol. 2018 Aug;13(8):1229.

PMID:
29454048
20.

Exploration of the platelet proteome in patients with early-stage cancer.

Sabrkhany S, Kuijpers MJE, Knol JC, Olde Damink SWM, Dingemans AC, Verheul HM, Piersma SR, Pham TV, Griffioen AW, Oude Egbrink MGA, Jimenez CR.

J Proteomics. 2018 Apr 15;177:65-74. doi: 10.1016/j.jprot.2018.02.011. Epub 2018 Feb 10.

21.

Training and Validating a Portable Electronic Nose for Lung Cancer Screening.

van de Goor R, van Hooren M, Dingemans AM, Kremer B, Kross K.

J Thorac Oncol. 2018 May;13(5):676-681. doi: 10.1016/j.jtho.2018.01.024. Epub 2018 Feb 6.

PMID:
29425703
22.

Current perspective: Osimertinib-induced QT prolongation: new drugs with new side-effects need careful patient monitoring.

Schiefer M, Hendriks LEL, Dinh T, Lalji U, Dingemans AC.

Eur J Cancer. 2018 Mar;91:92-98. doi: 10.1016/j.ejca.2017.12.011.

PMID:
29413968
23.

Patterns of treatment and survival among older patients with stage III non-small cell lung cancer.

Driessen EJM, Schulkes KJG, Dingemans AC, van Loon JGM, Hamaker ME, Aarts MJ, Janssen-Heijnen MLG.

Lung Cancer. 2018 Feb;116:55-61. doi: 10.1016/j.lungcan.2017.12.013. Epub 2017 Dec 20.

PMID:
29413051
24.

The effect of itraconazole and rifampicin on the pharmacokinetics of osimertinib.

Vishwanathan K, Dickinson PA, So K, Thomas K, Chen YM, De Castro Carpeño J, Dingemans AC, Kim HR, Kim JH, Krebs MG, Chih-Hsin Yang J, Bui K, Weilert D, Harvey RD.

Br J Clin Pharmacol. 2018 Jun;84(6):1156-1169. doi: 10.1111/bcp.13534. Epub 2018 Mar 23.

PMID:
29381826
25.

Primary or Redo Posterior Sagittal Anorectoplasty without a Stoma: To Feed or Not to Feed?

Reck-Burneo CA, Skerrit C, Dingemans A, Lane VA, Sanchez AV, Weaver L, Wagner A, Jenkins N, Wood RJ, Levitt MA.

Eur J Pediatr Surg. 2017 Dec 12. doi: 10.1055/s-0037-1608805. [Epub ahead of print] No abstract available.

PMID:
29232722
26.

Does clinic visit education within a multidisciplinary center improve health literacy scores in caregivers of children with complex colorectal conditions?

Dingemans AJM, Reck CA, Vilanova-Sanchez A, Gonzalez DO, Gasior AC, Weaver LJ, Gagnon R, Hoover E, Sraha G, Levitt MA, Wood RJ.

J Pediatr Surg. 2017 Dec;52(12):1997-2000. doi: 10.1016/j.jpedsurg.2017.08.044. Epub 2017 Sep 2.

PMID:
29223544
27.

Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project.

Letovanec I, Finn S, Zygoura P, Smyth P, Soltermann A, Bubendorf L, Speel EJ, Marchetti A, Nonaka D, Monkhorst K, Hager H, Martorell M, Sejda A, Cheney R, Hernandez-Losa J, Verbeken E, Weder W, Savic S, Di Lorito A, Navarro A, Felip E, Warth A, Baas P, Meldgaard P, Blackhall F, Dingemans AM, Dienemann H, Dziadziuszko R, Vansteenkiste J, O'Brien C, Geiger T, Sherlock J, Schageman J, Dafni U, Kammler R, Kerr K, Thunnissen E, Stahel R, Peters S; European Thoracic Oncology Platform Lungscape Consortium.

J Thorac Oncol. 2018 Mar;13(3):413-425. doi: 10.1016/j.jtho.2017.11.117. Epub 2017 Nov 27.

PMID:
29191776
28.

Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project.

Kerr KM, Dafni U, Schulze K, Thunnissen E, Bubendorf L, Hager H, Finn S, Biernat W, Vliegen L, Losa JH, Marchetti A, Cheney R, Warth A, Speel EJ, Blackhall F, Monkhorst K, Jantus Lewintre E, Tischler V, Clark C, Bertran-Alamillo J, Meldgaard P, Gately K, Wrona A, Vandenberghe P, Felip E, De Luca G, Savic S, Muley T, Smit EF, Dingemans AC, Priest L, Baas P, Camps C, Weder W, Polydoropoulou V, Geiger TR, Kammler R, Sumiyoshi T, Molina MA, Shames DS, Stahel RA, Peters S; ETOP Lungscape Consortium.

Ann Oncol. 2018 Jan 1;29(1):200-208. doi: 10.1093/annonc/mdx629.

PMID:
29186353
29.

Emotion Regulation in Binge Eating Disorder: A Review.

Dingemans A, Danner U, Parks M.

Nutrients. 2017 Nov 22;9(11). pii: E1274. doi: 10.3390/nu9111274. Review.

30.

Cumulative incidence rates for CNS and non-CNS progression in two phase II studies of alectinib in ALK-positive NSCLC.

Gadgeel S, Shaw AT, Barlesi F, Crinò L, Yang JC, Dingemans AC, Kim DW, de Marinis F, Schulz M, Liu S, Gupta R, Kotb A, Ou SI.

Br J Cancer. 2018 Jan;118(1):38-42. doi: 10.1038/bjc.2017.395. Epub 2017 Nov 16.

31.

Why we should improve current practice of diagnosing and treating pulmonary large cell neuroendocrine carcinomas in patients with advanced disease.

Derks J, van Suylen RJ, Thunnissen E, den Bakker M, Groen H, Smit E, Damhuis R, van den Broek E, Speel EJ, Dingemans AC.

Eur Respir J. 2017 Oct 26;50(4). pii: 1701658. doi: 10.1183/13993003.01658-2017. Print 2017 Oct. No abstract available.

PMID:
29074548
32.

Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome.

Derks JL, Leblay N, Thunnissen E, van Suylen RJ, den Bakker M, Groen HJM, Smit EF, Damhuis R, van den Broek EC, Charbrier A, Foll M, McKay JD, Fernandez-Cuesta L, Speel EM, Dingemans AC; PALGA-Group.

Clin Cancer Res. 2018 Jan 1;24(1):33-42. doi: 10.1158/1078-0432.CCR-17-1921. Epub 2017 Oct 24.

PMID:
29066508
33.

Management of Progressive Pulmonary Nodules Found during and outside of CT Lung Cancer Screening Studies.

Meyer M, Vliegenthart R, Henzler T, Buergy D, Giordano FA, Kostrzewa M, Rathmann N, Brustugun OT, Crino L, Dingemans AC, Dusmet M, Fennell D, Grunenwald D, Huber RM, Moniuszko M, Mornex F, Papotti M, Pilz L, Senan S, Syrigos K, Pérol M, Gray JE, Schabel C, van Meerbeeck JP, van Zandwijk N, Zhou CC, Manegold C, Voigt W, Roessner ED.

J Thorac Oncol. 2017 Dec;12(12):1755-1765. doi: 10.1016/j.jtho.2017.09.1956. Epub 2017 Sep 27. Review.

PMID:
28962947
34.

Quality assessment of positron emission tomography scans: recommendations for future multicentre trials.

de Jong EEC, van Elmpt W, Hoekstra OS, Groen HJM, Smit EF, Boellaard R, Lambin P, Dingemans AC.

Acta Oncol. 2017 Nov;56(11):1459-1464. doi: 10.1080/0284186X.2017.1346824. Epub 2017 Aug 22.

PMID:
28830270
35.

Nintedanib reduces radiation-induced microscopic lung fibrosis but this cannot be monitored by CT imaging: A preclinical study with a high precision image-guided irradiator.

De Ruysscher D, Granton PV, Lieuwes NG, van Hoof S, Wollin L, Weynand B, Dingemans AM, Verhaegen F, Dubois L.

Radiother Oncol. 2017 Sep;124(3):482-487. doi: 10.1016/j.radonc.2017.07.014. Epub 2017 Jul 31.

PMID:
28774597
36.

Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK-positive Non-Small Cell Lung Cancer.

Yang JC, Ou SI, De Petris L, Gadgeel S, Gandhi L, Kim DW, Barlesi F, Govindan R, Dingemans AC, Crino L, Lena H, Popat S, Ahn JS, Dansin E, Golding S, Bordogna W, Balas B, Morcos PN, Zeaiter A, Shaw AT.

J Thorac Oncol. 2017 Oct;12(10):1552-1560. doi: 10.1016/j.jtho.2017.06.070. Epub 2017 Jul 6.

37.

Development and Validation of a Decision Tool for Early Identification of Adult Patients with Severe and Complex Eating Disorder Psychopathology in Need of Highly Specialized Care.

Dingemans AE, Goorden M, Lötters FJB, Bouwmans C, Danner UN, van Elburg AA, van Furth EF, Hakkaart-van Roijen L.

Eur Eat Disord Rev. 2017 Sep;25(5):366-372. doi: 10.1002/erv.2528. Epub 2017 Jun 29.

PMID:
28660699
38.

Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK-positive non-small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteria.

Gandhi L, Ou SI, Shaw AT, Barlesi F, Dingemans AC, Kim DW, Camidge DR, Hughes BGM, Yang JC, de Castro J, Crino L, Léna H, Do P, Golding S, Bordogna W, Zeaiter A, Kotb A, Gadgeel S.

Eur J Cancer. 2017 Sep;82:27-33. doi: 10.1016/j.ejca.2017.05.019. Epub 2017 Jul 10.

PMID:
28646771
39.

[Measuring changes during the treatment of eating disorders: a comparison of two types of questionnaires].

Dingemans AE, van Furth EF.

Tijdschr Psychiatr. 2017;59(5):278-285. Dutch.

40.

Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?

Derks JL, van Suylen RJ, Thunnissen E, den Bakker MA, Groen HJ, Smit EF, Damhuis RA, van den Broek EC, Speel EM, Dingemans AC; PALGA group.

Eur Respir J. 2017 Jun 1;49(6). pii: 1601838. doi: 10.1183/13993003.01838-2016. Print 2017 Jun.

41.

Sociodemographics and the impact of a colostomy to indigent families and children with colorectal disorders in Honduras.

Krois W, Dingemans AJM, Hernández PX, Metzelder ML, Craniotis Rios J, Reck-Burneo CA.

J Pediatr Surg. 2018 Apr;53(4):841-846. doi: 10.1016/j.jpedsurg.2017.05.009. Epub 2017 May 12.

PMID:
28528713
42.

A combination of platelet features allows detection of early-stage cancer.

Sabrkhany S, Kuijpers MJE, van Kuijk SMJ, Sanders L, Pineda S, Olde Damink SWM, Dingemans AC, Griffioen AW, Oude Egbrink MGA.

Eur J Cancer. 2017 Jul;80:5-13. doi: 10.1016/j.ejca.2017.04.010. Epub 2017 May 17.

PMID:
28527393
43.

Heat shock protein antagonists in early stage clinical trials for NSCLC.

Hendriks LEL, Dingemans AC.

Expert Opin Investig Drugs. 2017 May;26(5):541-550. doi: 10.1080/13543784.2017.1302428. Epub 2017 Mar 8. Review.

PMID:
28274158
44.

Screening for Brain Metastases in Resectable Non-Small Cell Lung Cancer.

Hendriks LE, Hochstenbag M, Dingemans AM.

J Thorac Oncol. 2017 Mar;12(3):e21. doi: 10.1016/j.jtho.2016.11.2220. No abstract available.

45.

Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology.

Gamarra F, Noël JL, Brunelli A, Dingemans AC, Felip E, Gaga M, Grigoriu BD, Hardavella G, Huber RM, Janes S, Massard G, Putora PM, Sculier JP, Schnabel PA, Ramella S, Van Raemdonck D, Meert AP.

Breathe (Sheff). 2016 Sep;12(3):249-255. doi: 10.1183/20734735.009116. Review.

46.

Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer.

van der Wekken AJ, Pelgrim R, 't Hart N, Werner N, Mastik MF, Hendriks L, van der Heijden EHFM, Looijen-Salamon M, de Langen AJ, Staal-van den Brekel J, Riemersma S, van den Borne BE, Speel EJM, Dingemans AC, Hiltermann TJN, van den Berg A, Timens W, Schuuring E, Groen HJM.

Clin Cancer Res. 2017 Aug 1;23(15):4251-4258. doi: 10.1158/1078-0432.CCR-16-1631. Epub 2017 Feb 9.

47.

Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life.

Breukink MB, Dingemans AJ, den Hollander AI, Keunen JE, MacLaren RE, Fauser S, Querques G, Hoyng CB, Downes SM, Boon CJ.

Clin Ophthalmol. 2016 Dec 20;11:39-46. doi: 10.2147/OPTH.S115685. eCollection 2017.

48.

Management of stage I and II nonsmall cell lung cancer.

McDonald F, De Waele M, Hendriks LE, Faivre-Finn C, Dingemans AC, Van Schil PE.

Eur Respir J. 2017 Jan 3;49(1). pii: 1600764. doi: 10.1183/13993003.00764-2016. Print 2017 Jan. Review.

49.

PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer.

van Loon J, Even AJG, Aerts HJWL, Öllers M, Hoebers F, van Elmpt W, Dubois L, Dingemans AC, Lalisang RI, Kempers P, Brans B, Winnepenninckx V, Speel EJ, Thunnissen E, Smits KM, Boellaard R, Vugts DJ, De Ruysscher D, Lambin P.

Radiother Oncol. 2017 Feb;122(2):267-273. doi: 10.1016/j.radonc.2016.11.020. Epub 2016 Dec 21.

PMID:
28012793
50.

Moderators of change in an Internet-based intervention for eating disorders with different levels of therapist support: What works for whom?

Aardoom JJ, Dingemans AE, Fokkema M, Spinhoven P, Van Furth EF.

Behav Res Ther. 2017 Feb;89:66-74. doi: 10.1016/j.brat.2016.11.012. Epub 2016 Nov 22.

PMID:
27907817

Supplemental Content

Loading ...
Support Center